Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2016-12-09 10:03:39 |
Versijas komentārs | Typing error corrected |
Teksts |
Recording of the Third Quarter 2016 Investor Conference Webinar
On
December 8 JSC „Olainfarm” organized its Investor Conference Online
Webinar. During the webinar the member of the management board of
JSC „Olainfarm” Salvis Lapiņš analyzed the financial results of
third quarter 2016 and informed about other recent activities
within the company. The profit forecast for 2016 have been
adjusted to 9 MEUR instead of previously announced 10 MEUR.
The recorded JSC “Olainfarm” webinar is available online:
http://ej.uz/OLF_Q3_2016_rec,
and the presentation, demonstrated during the webinar, is available
in the previously published company’s announcement:
http://ej.uz/OLF_Q3_2016_PDF.
Olainfarm
thanks all participants, who joined the webinar, and encourages
everybody to follow company’s announcements to get information on
the next webinar!
JSC
Olainfarm is one of the biggest pharmaceutical companies in Latvia
with more than 40 years of experience in production of medication
and chemical and pharmaceutical products. A basic principle of
company's operations is to produce reliable and effective top
quality products for Latvia and the rest of the world. Products
made by the Group are being exported to more than 35 countries of
the world, including the Baltics, Russia, other CIS, Europe, Asia,
North America and Australia.
Information
prepared by:
|
Pielikumi |
|